
Overview
F1 Pharma provides research and development services for the pharmaceutical industry. The company works in pharmaceutical technology, analytics, stability testing, and quality assurance. It also carries out comprehensive development of medicinal products, including new drug forms.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $1,679 |
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 89 days for 2021). All were audited by a statutory auditor.
- 202514/07/2026
- 202429/08/2025
- 202309/07/2024
- 202212/07/2023
- 202112/10/2022
- 202028/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Medicinal product development
- Preformulation studies
- Production process optimization
- Analytical methods
- Stability testing
- Registration documentation
Websites
- f1pharma.plF1Pharma – rozwiązania badawczo-rozwojowe dla przemysłu farmaceutycznegoNginx
Job offers
The company lists 1 job opening on its own careers page: f1pharma.pl/kariera.
Authorized Representatives
Manner of representation
The company is represented by two members of the management board acting jointly.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-11-17.
69 2490 0005 0000 4520 2263 1981
13 2490 0005 0000 4600 7471 7546
38 2490 0005 0000 4600 6769 4199
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 4, 2024 | Shareholders' meeting convened | |
| Dec 11, 2020 | Commercial Companies Code notice | |
| Nov 26, 2020 | Commercial Companies Code notice | |
| Oct 26, 2020 | Commercial Companies Code notice | |
| Oct 9, 2020 | Commercial Companies Code notice |
Public aid
9 public aid cases recorded, with a total value of $1,035,930.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $79,573$79,573 | Polski Fundusz Rozwoju S.A. | |
| Aug 22, 2018 | Aid for research and development projects: industrial research | $488.6K$488,627 | Marszałek Województwa Małopolskiego | |
| Aug 22, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $93,524$93,524 | Marszałek Województwa Małopolskiego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pikralida sp. z o.o. | $1,151,165.63 | pikralida.eu | ||
| MT Laboratories sp. z o.o. | $489,455.67 | mtlab.pl | ||
| Mikrografia sp. z o.o. | $426,841.04 | mikrografia.eu | ||
| Green Zebras S.A. | $328,658.91 | whygreenzebras.pl | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Albi-Tech sp. z o.o. | $288,607.46 | albi-tech.pl | ||
| Globe Badania Kliniczne sp. z o.o. | $283,646.38 | globebadania.pl | ||
| Genelytica sp. z o.o. | $213,207.91 | genelytica.pl | ||
| TCI sp. z o.o. | $218,471.87 | tci.pl | ||
| Rebread Alcohol & Beverages sp. z o.o. | $103,277.29 | rebread.com |
FAQ
Last updated: 2026-10-03
